Reintervention-study After Previous Renal Denervation in Non-responding Patients With Severe Hypertension (RETREAT)

This study is currently recruiting participants.
Verified June 2013 by Cardiovascular Center Frankfurt
Sponsor:
Information provided by (Responsible Party):
Prof. Dr. Horst Sievert, Cardiovascular Center Frankfurt
ClinicalTrials.gov Identifier:
NCT01834118
First received: April 15, 2013
Last updated: June 10, 2013
Last verified: June 2013

April 15, 2013
June 10, 2013
June 2013
August 2013   (final data collection date for primary outcome measure)
Office Blood pressure measurement [ Time Frame: up to1 year ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01834118 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Reintervention-study After Previous Renal Denervation in Non-responding Patients With Severe Hypertension
Reintervention After Previous Renal Denervation in Non-responding Patients With Severe Hypertension

The purpose of this study is to determine the effect of repeated renal denervation in non-responding patients with severe hypertension. Therefore ultrasound technique will be used.

Renal Denervation is a CE-certified opportunity for treating patients with therapy-refractory hypertension. In some patients it doesn't show a significant lowering of the blood pressure, so a repeated renal denervation is an option.

In this study repeated renal denervation will be performed with the Recor Paradise Ultrasound Catheter.

For the study no specific procedures are required which would exceed the standard renal denervation procedure with the CE-certified Recor Paradise Ultrasound Catheter System.

There are no additional risks for the patient in consequence of participating in the study or the follow up procedures.

Observational [Patient Registry]
Observational Model: Cohort
Time Perspective: Prospective
1 Year
Not Provided
Probability Sample

Patients with treatment-resistant hypertension, who already underwent renal denervation with no therapeutic avail.

Hypertension, Resistant to Conventional Therapy
Procedure: Renal Denervation
Sympathetic nerve ablation via transcatheter renal denervation
Other Name: Renal sympathetic nerve ablation
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
20
August 2014
August 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Individual is ≥18 years old
  • Individual received renal denervation ≥12 months prior to study participation to no therapeutical avail and is scheduled for reintervention.
  • Systolic Office based blood pressure ≥140mmHg
  • Individual receives 3 or more antihypertensive drugs including one diuretic
  • Individual is willing to provide written informed consent to participate in this study

Exclusion Criteria:

  • Individual has hypertension secondary to an identifiable and treatable cause
  • Individual has any serious medical condition which in the opinion of the investigator may adversely affect the participation.
  • Individual is pregnant, nursing or planning to be pregnant
  • Renal artery abnormalities which may affect the procedure
Both
18 Years and older
No
Contact: Roger Eckhardt 0049 69 97947653 r.eckhardt@cvcfrankfurt.de
Germany
 
NCT01834118
CVC-001
No
Prof. Dr. Horst Sievert, Cardiovascular Center Frankfurt
Cardiovascular Center Frankfurt
Not Provided
Principal Investigator: Horst Sievert, M.D. Cardiovascular Center Frankfurt
Cardiovascular Center Frankfurt
June 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP